Advertisement

Interleukin Genetics Inc. (OTCQB: ILIU) of Waltham and its partner, the University of Michigan School of Dentistry, said they have completed patient enrollment for a clinical study using Interleukin’s PST genetic test, which may predict periodontal disease.

SOURCE

Advertisement
Advertisement